The fact that everything looks different doesn't mean that all has changed...
Biblio
Export 31 results:
Author Title Type [ Year
] Filters: First Letter Of Last Name is M [Clear All Filters]
. Investigation on the role of biallelic variants in VEGF‐C found in a patient affected by Milroy‐like lymphedema. Molecular Genetics & Genomic Medicine [Internet]. 2020;00:e1389. https://onlinelibrary.wiley.com/doi/abs/10.1002/mgg3.1389
Mukenge et al. 2020 (1.06 MB)
Mukenge et al. 2020 (1.06 MB). Investigation on the role of biallelic variants in VEGF‐C found in a patient affected by Milroy‐like lymphedema. Molecular Genetics & Genomic Medicine [Internet]. 2020;00:e1389. https://onlinelibrary.wiley.com/doi/abs/10.1002/mgg3.1389 Mukenge et al. 2020 (1.06 MB)
Mukenge et al. 2020 (1.06 MB). VEGF-C Protects the Integrity of Bone Marrow Perivascular Niche. Blood [Internet]. 2020;:accepted - for publication. https://ashpublications.org/blood/article/doi/10.1182/blood.2020005699/463465/VEGF-C-Protects-the-Integrity-of-Bone-Marrow Fang et al. 2020 - VEGF-C protects the integrity of bone marrow perivascular niche (6 MB)
Fang et al. 2020 - VEGF-C protects the integrity of bone marrow perivascular niche (6 MB). KLK3/PSA and cathepsin D activate VEGF-C and VEGF-D. eLife [Internet]. 2019;8:e44478. https://elifesciences.org/articles/44478 Jha & Rauniyar et al. 2019 (3.84 MB)
Jha & Rauniyar et al. 2019 (3.84 MB). KLK3/PSA and cathepsin D activate VEGF-C and VEGF-D. eLife [Internet]. 2019;8:e44478. https://elifesciences.org/articles/44478 Jha & Rauniyar et al. 2019 (3.84 MB)
Jha & Rauniyar et al. 2019 (3.84 MB). The genetic causes of primary lymphedema. In: . Erkrankungen des Lymphgefäßsystems. 6th ed. Cologne: Viavital Verlag; 2015. pp. 210-229. Mattonet et al. 2015: The genetic causes of primary lymphedema. [English] (3.8 MB) Mattonet et al. 2015: The genetic causes of primary lymphedema. [German] (676.52 KB)
Mattonet et al. 2015: The genetic causes of primary lymphedema. [English] (3.8 MB) Mattonet et al. 2015: The genetic causes of primary lymphedema. [German] (676.52 KB). Heterogeneity of the origin of the lymphatic system. [German]. Lymphologie in Forschung und Praxis [Internet]. 2015;19(2):84-88. http://www.dglymph.de/fileadmin/global/pdfs/LymphForsch_2-15.pdf Mattonet & Jeltsch 2015: Heterogeneity of the origin of the lymphatic system. (3.58 MB) Mattonet & Jeltsch 2015: Über die heterogene Herkunft des Lymphgefäßsystems. (288.77 KB)
Mattonet & Jeltsch 2015: Heterogeneity of the origin of the lymphatic system. (3.58 MB) Mattonet & Jeltsch 2015: Über die heterogene Herkunft des Lymphgefäßsystems. (288.77 KB). Substrate efflux propensity is the key determinant of iPLA-β-mediated glycerophospholipid hydrolysised. Journal of Biological Chemistry [Internet]. 2015;. http://www.jbc.org/content/early/2015/02/23/jbc.M115.642835.abstract J. Biol. Chem.-2015-Batchu-jbc.M115.642835.pdf (786.13 KB)
J. Biol. Chem.-2015-Batchu-jbc.M115.642835.pdf (786.13 KB). Structural and mechanistic insights into VEGF receptor 3 ligand binding and activation. Proceedings of the National Academy of Sciences of the United States of America [Internet]. 2013;110(32):12960 - 12965. http://www.pnas.org/content/110/32/12960.long
. A truncation allele in vascular endothelial growth factor c reveals distinct modes of signaling during lymphatic and vascular development. Development. 2013;140(7):1497-506. Villefranc 2013 (7.86 MB)
Villefranc 2013 (7.86 MB). Claudin-like protein 24 interacts with the VEGFR-2 and VEGFR-3 pathways and regulates lymphatic vessel development. Genes Dev [Internet]. 2010;24(9):875 - 80. http://view.ncbi.nlm.nih.gov/pubmed/20439428 Pipsa Saharinen et al., Genes & Development 2010 (1.2 MB) Pipsa Saharinen et al., Genes & Development 2010, supplement (9.15 MB)
Pipsa Saharinen et al., Genes & Development 2010 (1.2 MB) Pipsa Saharinen et al., Genes & Development 2010, supplement (9.15 MB). Vascular endothelial growth factor-B acts as a coronary growth factor in transgenic rats without inducing angiogenesis, vascular leak, or inflammation. Circulation [Internet]. 2010;122(17):1725 - 33. http://view.ncbi.nlm.nih.gov/pubmed/20937974 Maija Bry et al., Circulation 2010 (2.23 MB) Maija Bry et al., Circulation 2010, supplement (17.77 MB)
Maija Bry et al., Circulation 2010 (2.23 MB) Maija Bry et al., Circulation 2010, supplement (17.77 MB). Overexpression of vascular endothelial growth factor-B in mouse heart alters cardiac lipid metabolism and induces myocardial hypertrophy. Circ Res [Internet]. 2008;103(9):1018 - 26. http://view.ncbi.nlm.nih.gov/pubmed/18757827 Terhi Kärpänen et al., Circulation Research 2008 (898.27 KB) Terhi Kärpänen et al., Circulation Research 2008, supplement (1.56 MB)
Terhi Kärpänen et al., Circulation Research 2008 (898.27 KB) Terhi Kärpänen et al., Circulation Research 2008, supplement (1.56 MB). Overexpression of vascular endothelial growth factor-B in mouse heart alters cardiac lipid metabolism and induces myocardial hypertrophy. Circ Res [Internet]. 2008;103(9):1018 - 26. http://view.ncbi.nlm.nih.gov/pubmed/18757827 Terhi Kärpänen et al., Circulation Research 2008 (898.27 KB) Terhi Kärpänen et al., Circulation Research 2008, supplement (1.56 MB)
Terhi Kärpänen et al., Circulation Research 2008 (898.27 KB) Terhi Kärpänen et al., Circulation Research 2008, supplement (1.56 MB). Reevaluation of the role of VEGF-B suggests a restricted role in the revascularization of the ischemic myocardium. Arterioscler Thromb Vasc Biol [Internet]. 2008;28(9):1614 - 20. http://view.ncbi.nlm.nih.gov/pubmed/18511699 Xuri Li et al., Arteriosclerosis, Thrombosis, and Vascular Biology 2008 (738.26 KB) Xuri Li et al., Arteriosclerosis, Thrombosis, and Vascular Biology 2008, data supplement (1012.6 KB)
Xuri Li et al., Arteriosclerosis, Thrombosis, and Vascular Biology 2008 (738.26 KB) Xuri Li et al., Arteriosclerosis, Thrombosis, and Vascular Biology 2008, data supplement (1012.6 KB). Distinct architecture of lymphatic vessels induced by chimeric vascular endothelial growth factor-C/vascular endothelial growth factor heparin-binding domain fusion proteins. Circ Res [Internet]. 2007;100(10):1468 - 75. http://view.ncbi.nlm.nih.gov/pubmed/17478733 Tuomas Tammela et al., Circulation Research 2007 (1.1 MB)
Tuomas Tammela et al., Circulation Research 2007 (1.1 MB). Enhanced capillary formation stimulated by a chimeric vascular endothelial growth factor/vascular endothelial growth factor-C silk domain fusion protein. Circ Res [Internet]. 2007;100(10):1460 - 7. http://view.ncbi.nlm.nih.gov/pubmed/17478734 Salla Keskitalo et al., Circulation Research 2007 (1.98 MB)
Salla Keskitalo et al., Circulation Research 2007 (1.98 MB). Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J Clin Invest [Internet]. 2005;115(2):247 - 57. http://view.ncbi.nlm.nih.gov/pubmed/15668734 Peter Baluk et al., Journal of Clinical Investigation 2005 (1.89 MB)
Peter Baluk et al., Journal of Clinical Investigation 2005 (1.89 MB). Intrinsic versus microenvironmental regulation of lymphatic endothelial cell phenotype and function. FASEB J [Internet]. 2003;17(14):2006 - 13. http://view.ncbi.nlm.nih.gov/pubmed/14597670 Tanja Veikkola et al., FASEB Journal 2006 (598.77 KB)
Tanja Veikkola et al., FASEB Journal 2006 (598.77 KB). VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol [Internet]. 2003;161(6):1163 - 77. http://view.ncbi.nlm.nih.gov/pubmed/12810700 Holger Gerhardt et al., The Journal of Biological Chemistry 2003 (2.24 MB)
Holger Gerhardt et al., The Journal of Biological Chemistry 2003 (2.24 MB). Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J [Internet]. 2001;20(6):1223 - 31. http://view.ncbi.nlm.nih.gov/pubmed/11250889 Tanja Veikkola et al., EMBO Journal 2001 (491.14 KB)
Tanja Veikkola et al., EMBO Journal 2001 (491.14 KB). Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J [Internet]. 2001;20(6):1223 - 31. http://view.ncbi.nlm.nih.gov/pubmed/11250889 Tanja Veikkola et al., EMBO Journal 2001 (491.14 KB)
Tanja Veikkola et al., EMBO Journal 2001 (491.14 KB). Signalling via VEGFR-3 is sufficient for lymphangiogenesis in transgenic mice. In Molecular Targets and Cancer Therapeutics: Discovery, Biology, and Clinical Applications. Miami Beach, Florida; 2001. Jussila et al., 2001 (279.47 KB)
Jussila et al., 2001 (279.47 KB). Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J [Internet]. 2001;20(4):672 - 82. http://view.ncbi.nlm.nih.gov/pubmed/11179212 Stefano Mandriota et al., EMBO Journal 2001 (736.96 KB)
Stefano Mandriota et al., EMBO Journal 2001 (736.96 KB). Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J [Internet]. 2001;20(4):672 - 82. http://view.ncbi.nlm.nih.gov/pubmed/11179212 Stefano Mandriota et al., EMBO Journal 2001 (736.96 KB)
Stefano Mandriota et al., EMBO Journal 2001 (736.96 KB)